Streetbeat News

Products Services

STRO

Sutro Biopharma (NASDAQ:STRO) was analyzed by 10 analysts, showing a mix of bullish and somewhat bullish ratings. The average 12-month price target is now $12.5, down 11.79% from $14.17, with a high estimate of $18.00 and a low of $8.00. Analyst actions include maintaining, lowering, and raising ratings and price targets, reflecting their response to the company's performance and market conditions. Sutro Biopharma, a clinical-stage company focusing on cancer and autoimmune disorders, has shown significant financial growth, with a revenue increase of 1217.44% and a net margin of 27.32%.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 1:00 pm

COEP

Coeptis Therapeutics announced it will present its universal allogeneic SNAP-CAR NK cell therapy at the International Society for Cell & Gene Therapy (ISCT) 2024 conference, scheduled from May 28 to June 1.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:56 pm

REBN

Reborn Coffee Inc. (NASDAQ:REBN) has announced a major expansion into the China market through a Master License Agreement with IAID Co., Ltd. This partnership aims to introduce Reborn Coffee's specialty coffee in China, starting with a flagship location in Guangzhou. The venture plans future expansions in major cities and aims to revolutionize coffee culture in the Guangdong Province.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:41 pm

PRFX

PainReform Ltd. CEO Ilan Hadar discussed the benefits of PRF-110 in addressing the opioid crisis, highlighting its extended post-operative pain relief capabilities without opioids and positive Phase 3 trial updates. The interview was conducted by Proactiveinvestors.com.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:39 pm

BLNK

Blink Charging Co. (NASDAQ:BLNK) announced the launch of Blink Care, a new optional preventative maintenance program for its electric vehicle (EV) charging stations. Designed to reduce charger downtime and enhance the charging experience, Blink Care offers detailed maintenance services, including on-site check-ups, equipment cleaning, and comprehensive reports. The program is available for both Level 2 and DC fast chargers, with additional services for DC fast chargers.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:35 pm

RDDT

Reddit, Inc. (NYSE:RDDT) shares surged in premarket trading following its first post-IPO earnings report, despite missing analyst expectations for quarterly losses. The company reported a significant increase in gross margin and adjusted EBITDA, along with strong Q2 revenue guidance. CEO Steve Huffman highlighted Reddit's unique appeal across various age demographics, suggesting a competitive edge in user engagement and commercialization.

Portfolio Pulse from Nabaparna Bhattacharya

May 08, 2024 | 12:34 pm

SHOP

SLNH

TRIP

Shopify's shares dropped 19% after Q1 earnings report. TripAdvisor's shares fell 18% as Liberty Tripadvisor and the Special Committee ended talks for a potential transaction. Soluna's shares surged 59% following the launch of an AI Cloud Service in collaboration with a global enterprise GPU-server OEM.

Portfolio Pulse from ryanfaloona@benzinga.com

May 08, 2024 | 12:34 pm

ANIX

Anixa Biosciences has announced a partnership with Cleveland Clinic to develop cancer vaccines, aiming to leverage their combined expertise to advance cancer treatment options.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:27 pm

PRQR

ProQR Therapeutics NV (NASDAQ:PRQR) announced new preclinical data for its Axiomer RNA editing technology, including proof of concept for its AX-0810 program targeting NTCP for cholestatic diseases. The data, presented at the ASGCT Annual Meeting, shows meaningful changes in biomarkers in NHPs, marking a significant step towards clinical trials. A management webinar is scheduled for May 9, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:27 pm

UBER

Uber's CEO announced that the company will start offering exclusive events and experiences to its paid members, aiming to enhance the value of its membership program.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:24 pm